News

Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today ...
SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...
Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.
Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...
SEATTLE -- Psychological evaluation before implantation of a hypoglossal nerve stimulation (HNS) device to treat obstructive ...
According to a new study, presented at the American College of Cardiology (ACC) Care of the Athletic Heart 2025 conference, ...
Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which ...
Capital structure streamlined and potential dilution from Series A Warrants eliminated ahead of key Phase 2 clinical milestonesNEW YORK and MELBOURNE, Australia, June 12, 2025 (GLOBE NEWSWIRE) -- ...
Some groups are at higher risk for complications, including children and people with underlying health conditions ...